Stroke Trial, Recruiting NCT05902195 Sponsor: Chinese University of Hong Kong Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT05902195
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 18 and 64 years old
  • People who have been clinically diagnosed with a first or repeat stroke (either ischaemic, caused by a blocked blood vessel, or haemorrhagic, caused by bleeding in the brain)
  • People who are living at home at the time of the study
  • People whose thinking and memory abilities are above a certain minimum level, as measured by a standard assessment called the Montreal Cognitive Assessment (confirm with trial site for exact score requirement)
  • People with a disability level rated as "moderately severe" or lower on a standard stroke recovery scale called the Modified Rankin Scale
  • People who are able to speak Cantonese and read Traditional Chinese
  • People who were in regular paid employment at the time of their stroke
  • People who have been out of work for at least 3 months by the time they are enrolled in the trial

Who may not be able to join:

  • People who have been diagnosed with a transient ischaemic attack (sometimes called a "mini-stroke") rather than a full stroke
  • People whose stroke or brain event was caused by a tumour
  • People who have been diagnosed with a mental health condition such as depression, schizophrenia, or bipolar disorder
  • People who have significant difficulty speaking clearly or understanding conversations
  • People who are currently taking part in, or have already completed, a vocational (work-related) rehabilitation programme

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Suzanne Lo, Chinese University of Hong Kong

Phone: 852 3943 4485

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2023
Est. completion
31 December 2027

Where this trial is recruiting

Hong Kong

Primary endpoints

Change in the level of perceived work ability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov